Genetic an Functional Studies of Patient With Inflammatory Bowel Disease
NCT03751722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 630
Last updated 2018-11-23
Summary
The objective of this study is to study the response of macrophages, isolated from patients with ulcerative colitis (Crohn's disease) or Crohn's disease (CD), to 6 candidate enterogenous and their derivatives, depending on the genotype for associated polymorphisms. to the development of IBD
Conditions
- Inflammatory Bowel Diseases
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Principal Investigators
-
Corinne Gower-Rousseau, MD, PhD · University Hospital, Lille
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2017-04-10
- Completion
- 2017-04-10
Countries
- France
Study Locations
More Related Trials
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Gene Expression in Inflammatory Bowel Disease
NCT01171872 ·Status: ENROLLING_BY_INVITATION
-
Characterization of Phenotype and Genotype of Early Onset Enteropathies
NCT02614911 ·Status: RECRUITING
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort
NCT02502552 ·Status: COMPLETED
-
Early Inflammatory Bowel Disease Progression
NCT06756100 ·Status: RECRUITING
-
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
NCT03809728 ·Status: RECRUITING ·Phase: NA
-
Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2011).
NCT02392221 ·Status: COMPLETED
-
Remote Monitoring of IBD
NCT05886322 ·Status: UNKNOWN
-
Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease
NCT02770495 ·Status: COMPLETED ·Phase: PHASE3
-
NKT Role in the Regulation of the Inflammatory Bowel Disease
NCT02884557 ·Status: COMPLETED ·Phase: NA
-
Genetic Studies of Inflammatory Bowel Disease
NCT00340444 ·Status: COMPLETED
-
Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease
NCT00561548 ·Status: TERMINATED ·Phase: NA
-
Study of Inflammatory Markers (VNN1) in Crohn Disease and Ulcerative Colitis.
NCT02304666 ·Status: UNKNOWN ·Phase: NA
-
The Innate Immune System and Inflammatory Bowel Disease
NCT00516776 ·Status: COMPLETED
-
STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
NCT04973423 ·Status: RECRUITING ·Phase: NA
-
Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities
NCT01216514 ·Status: COMPLETED
-
Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease
NCT02909244 ·Status: COMPLETED
-
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
NCT02826330 ·Status: COMPLETED
-
Impact of Obesity on Response to Therapy and Clinical Outcom in Patients With Inflammatory Bowel Disease
NCT07343726 ·Status: NOT_YET_RECRUITING
-
Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)
NCT07167186 ·Status: NOT_YET_RECRUITING
-
Search for New Genetic Mutations Major Effect in Crohn's Disease
NCT02851134 ·Status: COMPLETED
-
Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin
NCT06972901 ·Status: RECRUITING ·Phase: NA
-
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
NCT06453720 ·Status: RECRUITING
-
Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease
NCT01891214 ·Status: COMPLETED